Tech Company Financing Transactions

Glyphic Biotechnologies Funding Round

Glyphic Biotechnologies closed a $6 million Seed financing round on 7/28/2021. Backers included OMX Ventures, ARTIS Ventures and Axial.

Transaction Overview

Announced On
7/28/2021
Transaction Type
Venture Equity
Amount
$6,025,000
Round
Seed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2261 Market St. 4403
San Francisco, CA 94114
USA
Phone
Undisclosed
Email Address
Overview
At Glyphic Biotechnologies, we are creating the protein revolution for which scientists and researchers have been waiting. Our team is comprised of talented scientists, engineers, and people who care about changing the underlying engines of biomedical discovery.
Profile
Glyphic Biotechnologies LinkedIn Company Profile
Social Media
Glyphic Biotechnologies Company Twitter Account
Company News
Glyphic Biotechnologies News
Facebook
Glyphic Biotechnologies on Facebook
YouTube
Glyphic Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joshua Yang
  Joshua Yang LinkedIn Profile  Joshua Yang Twitter Account  Joshua Yang News  Joshua Yang on Facebook
Chief Technical Officer
Daniel Estandian
  Daniel Estandian LinkedIn Profile  Daniel Estandian Twitter Account  Daniel Estandian News  Daniel Estandian on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/28/2021: PsiQuantum venture capital transaction
Next: 7/28/2021: At-Bay venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary